What are the risks of menopause hormone therapy?

Women weighing hormone therapy usually ask about risk before anything else. The Menopause Society gives a direct list, and a timeline that matters as much as the list itself.
The risks named by The Menopause Society
The Menopause Society says systemic hormones are very effective for hot flashes and have other benefits, such as protecting bones. It also says they carry risks, such as blood clots and breast cancer.
The Menopause Society also lists common side effects. Hormone therapy can cause breast tenderness, nausea, and irregular bleeding or spotting.
Timing changes the breast cancer picture
The Menopause Society says the breast cancer risk usually does not rise until after about 5 years with estrogen plus progestogen therapy, or after 7 years with estrogen alone.
The source describes the risk by how long therapy lasts, not only by whether it is used. For more on who needs which combination, read whether women with a uterus need progestogen.
Where to read further
The Menopause Society's hormone therapy topic page is the source for the points above. WebMD covers menopause and HRT, including types, benefits, risks and side effects, and the Endocrine Society has a library entry on menopause.
What to do next
Take the risk list and the timing to a clinician who knows your history. These pages help you prepare:
A Westfield view on timing
This desk is in Westfield, New Jersey, where our answers lean on timing. For hormone therapy the source ties breast cancer risk to years of use, so a note of your start date is worth keeping. The New York metropolitan area page shows how far that coverage reaches.